JACKELIN SMITH: Open Payments
NPI 1083175871 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 52 payments from 14 companies in 2025. Trend: 2023 $460 · 2024 $1,409 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 11 | $343 |
| Melinta Therapeutics, LLC | 5 | $201 |
| Aimmune Therapeutics, Inc. | 5 | $174 |
| Insmed, Inc. | 14 | $162 |
| Novo Nordisk Inc | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $109 |
| PFIZER INC. | 1 | $100 |
| United Therapeutics Corporation | 1 | $86 |
| ViiV Healthcare Company | 3 | $85 |
| Shionogi Inc | 3 | $79 |
Products named: NUZYRA, Rezzayo, Arikayce, ZENPEP, Ozempic, COMIRNATY, DOVATO, Fetroja.
Industry payments across FL — which companies pay providers there.
